Poultry probiotic's coat clues to ability to battle bugs

Nov 18, 2013
This is a Transmission Electron Micrograph of normal, wild type (left) and EPS cluster mutant (right) L. johnsonii. The mutant on the right has a much reduced EPS coat. Credit: IFR

IFR researchers have characterised the coat of a potential poultry probiotic, giving the first clues of how it may be used to exclude pathogenic bacteria from chickens.

Lactobacillus johnsonii has previously been shown to exclude Clostridium perfringens from the guts of , opening the door to it being developed as a way of reducing necrotic enteritis in poultry and food poisoning in humans. Recently, researchers at the Institute of Food Research, which is strategically supported by the Biotechnology and Biological Sciences Research Council, found that the make coats for themselves that play important roles in in this strain.

Now, in a study published in The Journal of Biological Chemistry, the researchers present the first characterisation of what makes up this coat. This will give us a better idea of the role of the coat and help in the development of these bacteria as a way of combatting C. perfringens.

Using NMR spectroscopy, the researchers discovered that the coat is made up of two types of exopolysaccharides (EPS), which are long sugar-containing molecules that many bacteria use to encapsulate themselves. This capsule may help the bacteria to cope with environmental stress, or aid colonisation and adhesion. Different bacterial strains have different EPS structures, and understanding this is important as they represent a key way bacteria interact with the world around them.

'Characterising the EPS structures in the L. johnsonii strain is the first step to explaining how it might outcompete C. perfringens.' said Dr Arjan Narbad.

Previous studies had identified potential genes in L. johnsonii for producing EPS, giving the researchers tools to probe how the bacteria synthesise these molecules. Knocking out the whole cluster of EPS genes meant the bacteria produced no capsule. Further analysis of the genes by IFR PhD student Enes Dertli uncovered their potential roles in the capsule biosynthesis process but more research is needed to fully understand the system, and also how it is regulated.

The structures of these two EPS molecules appear to be unique to this strain. Structural features, such as the phosphorylation patterns, are likely to be a major influence on how well bacteria adhere. Other structural modifications such as acetylation are thought to help protect the EPS from the enzymes produced by .

This strain of Lactobacillus johnsonii is now being taken through farm-scale trials to assess its potential use to combat pathogenic infections of poultry by bacteria such as C. perfringens. This study provides insights into exactly how this works, and future work will focus on unpicking how the EPS molecules in the coat contribute to colonisation and pathogen exclusion.

Explore further: How bacteria with a sweet tooth may keep us healthy

More information: 'Structure and Biosynthesis of Two Exopolysaccharides Produced by Lactobacillus johnsonii FI9785', Journal of Biological Chemistry, 288(44):31938-51. DOI: 10.1074/jbc.M113.507418

add to favorites email to friend print save as pdf

Related Stories

Microbes that immobilize

Jun 02, 2011

Using a model organism isolated from a uranium seep of the Columbia River, scientists recently quantified how extracellular polymeric substances (EPS) in subsurface environments can be used to immobilize heavy ...

Triple threat: One bacterium, three plasmids

Nov 14, 2011

Researchers from Australia found something completely new while conducting a genetic study of the pathogenesis of an enteric disease in birds. They report what is believed to be the first bacterial strain to carry three closely ...

Recommended for you

Breakthrough points to new drugs from nature

Apr 16, 2014

Researchers at Griffith University's Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs.

World's first successful visualisation of key coenzyme

Apr 16, 2014

Japanese researchers have successfully developed the world's first imaging method for visualising the behaviour of nicotine-adenine dinucleotide derivative (NAD(P)H), a key coenzyme, inside cells. This feat ...

User comments : 0

More news stories

Poll: Big Bang a big question for most Americans

Few Americans question that smoking causes cancer. But they have more skepticism than confidence in global warming, the age of the Earth and evolution and have the most trouble believing a Big Bang created the universe 13.8 ...

Making graphene in your kitchen

Graphene has been touted as a wonder material—the world's thinnest substance, but super-strong. Now scientists say it is so easy to make you could produce some in your kitchen.